nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—PTGS1—malignant glioma	0.0265	1	CrCbGaD
Nabilone—Cerebration impaired—Temozolomide—malignant glioma	0.0156	0.0239	CcSEcCtD
Nabilone—Paranoia—Carmustine—malignant glioma	0.0139	0.0213	CcSEcCtD
Nabilone—Apathy—Temozolomide—malignant glioma	0.0129	0.0196	CcSEcCtD
Nabilone—Flat affect—Temozolomide—malignant glioma	0.0127	0.0195	CcSEcCtD
Nabilone—Stupor—Carmustine—malignant glioma	0.0127	0.0194	CcSEcCtD
Nabilone—Scotoma—Carmustine—malignant glioma	0.0125	0.0191	CcSEcCtD
Nabilone—Scotoma—Temozolomide—malignant glioma	0.0121	0.0185	CcSEcCtD
Nabilone—Memory impairment—Temozolomide—malignant glioma	0.0117	0.0179	CcSEcCtD
Nabilone—Speech disorder—Carmustine—malignant glioma	0.0111	0.0169	CcSEcCtD
Nabilone—Speech disorder—Temozolomide—malignant glioma	0.0107	0.0163	CcSEcCtD
Nabilone—Disturbance in attention—Temozolomide—malignant glioma	0.0106	0.0162	CcSEcCtD
Nabilone—Thinking abnormal—Carmustine—malignant glioma	0.0104	0.0159	CcSEcCtD
Nabilone—Drug interaction—Carmustine—malignant glioma	0.0103	0.0157	CcSEcCtD
Nabilone—Coordination abnormal—Carmustine—malignant glioma	0.00968	0.0148	CcSEcCtD
Nabilone—Neck pain—Carmustine—malignant glioma	0.00962	0.0147	CcSEcCtD
Nabilone—Coordination abnormal—Temozolomide—malignant glioma	0.00936	0.0143	CcSEcCtD
Nabilone—Depressed level of consciousness—Carmustine—malignant glioma	0.00918	0.014	CcSEcCtD
Nabilone—Depressed level of consciousness—Temozolomide—malignant glioma	0.00887	0.0135	CcSEcCtD
Nabilone—Coma—Carmustine—malignant glioma	0.00869	0.0133	CcSEcCtD
Nabilone—Dry eye—Temozolomide—malignant glioma	0.00849	0.013	CcSEcCtD
Nabilone—Mental disability—Carmustine—malignant glioma	0.00825	0.0126	CcSEcCtD
Nabilone—Mental disability—Temozolomide—malignant glioma	0.00797	0.0122	CcSEcCtD
Nabilone—Nasal congestion—Temozolomide—malignant glioma	0.00732	0.0112	CcSEcCtD
Nabilone—Hot flush—Temozolomide—malignant glioma	0.00713	0.0109	CcSEcCtD
Nabilone—Menopausal symptoms—Temozolomide—malignant glioma	0.00707	0.0108	CcSEcCtD
Nabilone—CNR1—GPCRs, Other—CXCR3—malignant glioma	0.00703	0.0235	CbGpPWpGaD
Nabilone—Thirst—Temozolomide—malignant glioma	0.00701	0.0107	CcSEcCtD
Nabilone—Face oedema—Carmustine—malignant glioma	0.00666	0.0102	CcSEcCtD
Nabilone—Affect lability—Temozolomide—malignant glioma	0.00657	0.01	CcSEcCtD
Nabilone—Ataxia—Carmustine—malignant glioma	0.00649	0.00991	CcSEcCtD
Nabilone—Face oedema—Temozolomide—malignant glioma	0.00644	0.00983	CcSEcCtD
Nabilone—Mood swings—Temozolomide—malignant glioma	0.00632	0.00965	CcSEcCtD
Nabilone—Ataxia—Temozolomide—malignant glioma	0.00627	0.00958	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—CCR4—malignant glioma	0.00564	0.0188	CbGpPWpGaD
Nabilone—Sweating increased—Temozolomide—malignant glioma	0.00562	0.00858	CcSEcCtD
Nabilone—CNR1—telencephalon—malignant glioma	0.00541	0.288	CbGeAlD
Nabilone—Pollakiuria—Temozolomide—malignant glioma	0.00533	0.00813	CcSEcCtD
Nabilone—Depression—Carmustine—malignant glioma	0.0053	0.0081	CcSEcCtD
Nabilone—Photosensitivity reaction—Temozolomide—malignant glioma	0.00526	0.00804	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.00524	0.0175	CbGpPWpGaD
Nabilone—Stomatitis—Carmustine—malignant glioma	0.00518	0.00792	CcSEcCtD
Nabilone—Depression—Temozolomide—malignant glioma	0.00513	0.00783	CcSEcCtD
Nabilone—Stomatitis—Temozolomide—malignant glioma	0.00501	0.00765	CcSEcCtD
Nabilone—Hallucination—Carmustine—malignant glioma	0.00475	0.00725	CcSEcCtD
Nabilone—Hypoaesthesia—Carmustine—malignant glioma	0.00475	0.00725	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—NTRK2—malignant glioma	0.00474	0.0158	CbGpPWpGaD
Nabilone—Visual impairment—Carmustine—malignant glioma	0.0046	0.00703	CcSEcCtD
Nabilone—Hallucination—Temozolomide—malignant glioma	0.00459	0.00701	CcSEcCtD
Nabilone—Hypoaesthesia—Temozolomide—malignant glioma	0.00459	0.00701	CcSEcCtD
Nabilone—Pharyngitis—Temozolomide—malignant glioma	0.00458	0.00699	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00449	0.015	CbGpPWpGaD
Nabilone—Eye disorder—Carmustine—malignant glioma	0.00446	0.00681	CcSEcCtD
Nabilone—Visual impairment—Temozolomide—malignant glioma	0.00445	0.00679	CcSEcCtD
Nabilone—Flushing—Carmustine—malignant glioma	0.00443	0.00677	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—CCR4—malignant glioma	0.00443	0.0148	CbGpPWpGaD
Nabilone—CNR2—central nervous system—malignant glioma	0.00442	0.235	CbGeAlD
Nabilone—Eye disorder—Temozolomide—malignant glioma	0.00431	0.00658	CcSEcCtD
Nabilone—Tinnitus—Temozolomide—malignant glioma	0.0043	0.00657	CcSEcCtD
Nabilone—Flushing—Temozolomide—malignant glioma	0.00428	0.00654	CcSEcCtD
Nabilone—Arrhythmia—Carmustine—malignant glioma	0.00427	0.00651	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—CXCR3—malignant glioma	0.0042	0.014	CbGpPWpGaD
Nabilone—Chills—Temozolomide—malignant glioma	0.00414	0.00632	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.00411	0.0137	CbGpPWpGaD
Nabilone—Back pain—Carmustine—malignant glioma	0.00402	0.00614	CcSEcCtD
Nabilone—Vision blurred—Carmustine—malignant glioma	0.00392	0.00598	CcSEcCtD
Nabilone—Tremor—Carmustine—malignant glioma	0.00389	0.00595	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00389	0.013	CbGpPWpGaD
Nabilone—Back pain—Temozolomide—malignant glioma	0.00389	0.00593	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—NTRK1—malignant glioma	0.00386	0.0129	CbGpPWpGaD
Nabilone—Anaemia—Carmustine—malignant glioma	0.00384	0.00587	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—BDKRB2—malignant glioma	0.00384	0.0128	CbGpPWpGaD
Nabilone—Agitation—Carmustine—malignant glioma	0.00382	0.00583	CcSEcCtD
Nabilone—Vision blurred—Temozolomide—malignant glioma	0.00379	0.00578	CcSEcCtD
Nabilone—Tremor—Temozolomide—malignant glioma	0.00376	0.00575	CcSEcCtD
Nabilone—Ill-defined disorder—Temozolomide—malignant glioma	0.00373	0.00569	CcSEcCtD
Nabilone—Leukopenia—Carmustine—malignant glioma	0.00372	0.00568	CcSEcCtD
Nabilone—Anaemia—Temozolomide—malignant glioma	0.00371	0.00567	CcSEcCtD
Nabilone—Agitation—Temozolomide—malignant glioma	0.00369	0.00564	CcSEcCtD
Nabilone—Malaise—Temozolomide—malignant glioma	0.00362	0.00553	CcSEcCtD
Nabilone—Vertigo—Temozolomide—malignant glioma	0.00361	0.00551	CcSEcCtD
Nabilone—Convulsion—Carmustine—malignant glioma	0.0036	0.0055	CcSEcCtD
Nabilone—Leukopenia—Temozolomide—malignant glioma	0.0036	0.00549	CcSEcCtD
Nabilone—Hypertension—Carmustine—malignant glioma	0.00359	0.00548	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00356	0.0119	CbGpPWpGaD
Nabilone—CNR1—N-cadherin signaling events—PIK3CA—malignant glioma	0.00355	0.0118	CbGpPWpGaD
Nabilone—Palpitations—Temozolomide—malignant glioma	0.00355	0.00542	CcSEcCtD
Nabilone—Myalgia—Carmustine—malignant glioma	0.00354	0.0054	CcSEcCtD
Nabilone—Chest pain—Carmustine—malignant glioma	0.00354	0.0054	CcSEcCtD
Nabilone—Anxiety—Carmustine—malignant glioma	0.00353	0.00539	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00352	0.0117	CbGpPWpGaD
Nabilone—CNR2—brain—malignant glioma	0.00351	0.187	CbGeAlD
Nabilone—Cough—Temozolomide—malignant glioma	0.00351	0.00535	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—KNG1—malignant glioma	0.00349	0.0116	CbGpPWpGaD
Nabilone—Convulsion—Temozolomide—malignant glioma	0.00348	0.00531	CcSEcCtD
Nabilone—Hypertension—Temozolomide—malignant glioma	0.00347	0.0053	CcSEcCtD
Nabilone—Confusional state—Carmustine—malignant glioma	0.00342	0.00522	CcSEcCtD
Nabilone—Myalgia—Temozolomide—malignant glioma	0.00342	0.00522	CcSEcCtD
Nabilone—Arthralgia—Temozolomide—malignant glioma	0.00342	0.00522	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CCR4—malignant glioma	0.00342	0.0114	CbGpPWpGaD
Nabilone—Anxiety—Temozolomide—malignant glioma	0.00341	0.0052	CcSEcCtD
Nabilone—Discomfort—Temozolomide—malignant glioma	0.00338	0.00516	CcSEcCtD
Nabilone—Infection—Carmustine—malignant glioma	0.00337	0.00515	CcSEcCtD
Nabilone—Dry mouth—Temozolomide—malignant glioma	0.00334	0.00511	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00334	0.0111	CbGpPWpGaD
Nabilone—Tachycardia—Carmustine—malignant glioma	0.00331	0.00506	CcSEcCtD
Nabilone—Confusional state—Temozolomide—malignant glioma	0.00331	0.00505	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—CXCR3—malignant glioma	0.00329	0.011	CbGpPWpGaD
Nabilone—Infection—Temozolomide—malignant glioma	0.00326	0.00497	CcSEcCtD
Nabilone—Anorexia—Carmustine—malignant glioma	0.00323	0.00494	CcSEcCtD
Nabilone—Hypotension—Carmustine—malignant glioma	0.00317	0.00484	CcSEcCtD
Nabilone—Hyperhidrosis—Temozolomide—malignant glioma	0.00317	0.00484	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—SPP1—malignant glioma	0.00314	0.0105	CbGpPWpGaD
Nabilone—Anorexia—Temozolomide—malignant glioma	0.00313	0.00477	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00309	0.00472	CcSEcCtD
Nabilone—Insomnia—Carmustine—malignant glioma	0.00307	0.00469	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00306	0.0102	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00305	0.0102	CbGpPWpGaD
Nabilone—Paraesthesia—Carmustine—malignant glioma	0.00305	0.00465	CcSEcCtD
Nabilone—Dyspnoea—Carmustine—malignant glioma	0.00302	0.00462	CcSEcCtD
Nabilone—Somnolence—Carmustine—malignant glioma	0.00302	0.00461	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—BDKRB2—malignant glioma	0.00301	0.01	CbGpPWpGaD
Nabilone—CNR1—cerebellum—malignant glioma	0.003	0.16	CbGeAlD
Nabilone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00299	0.00456	CcSEcCtD
Nabilone—Insomnia—Temozolomide—malignant glioma	0.00297	0.00453	CcSEcCtD
Nabilone—Decreased appetite—Carmustine—malignant glioma	0.00295	0.0045	CcSEcCtD
Nabilone—Paraesthesia—Temozolomide—malignant glioma	0.00294	0.0045	CcSEcCtD
Nabilone—Dyspnoea—Temozolomide—malignant glioma	0.00292	0.00446	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—LATS2—malignant glioma	0.00292	0.00974	CbGpPWpGaD
Nabilone—Somnolence—Temozolomide—malignant glioma	0.00291	0.00445	CcSEcCtD
Nabilone—Pain—Carmustine—malignant glioma	0.0029	0.00443	CcSEcCtD
Nabilone—Constipation—Carmustine—malignant glioma	0.0029	0.00443	CcSEcCtD
Nabilone—Dyspepsia—Temozolomide—malignant glioma	0.00289	0.00441	CcSEcCtD
Nabilone—Decreased appetite—Temozolomide—malignant glioma	0.00285	0.00435	CcSEcCtD
Nabilone—Fatigue—Temozolomide—malignant glioma	0.00283	0.00432	CcSEcCtD
Nabilone—Constipation—Temozolomide—malignant glioma	0.0028	0.00428	CcSEcCtD
Nabilone—Pain—Temozolomide—malignant glioma	0.0028	0.00428	CcSEcCtD
Nabilone—Feeling abnormal—Carmustine—malignant glioma	0.0028	0.00427	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00279	0.00932	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00278	0.00926	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Carmustine—malignant glioma	0.00277	0.00424	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—KNG1—malignant glioma	0.00274	0.00913	CbGpPWpGaD
Nabilone—Feeling abnormal—Temozolomide—malignant glioma	0.0027	0.00413	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CCR4—malignant glioma	0.00268	0.00894	CbGpPWpGaD
Nabilone—Body temperature increased—Carmustine—malignant glioma	0.00268	0.0041	CcSEcCtD
Nabilone—Abdominal pain—Carmustine—malignant glioma	0.00268	0.0041	CcSEcCtD
Nabilone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00268	0.00409	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00262	0.00873	CbGpPWpGaD
Nabilone—Body temperature increased—Temozolomide—malignant glioma	0.00259	0.00396	CcSEcCtD
Nabilone—Abdominal pain—Temozolomide—malignant glioma	0.00259	0.00396	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—BAD—malignant glioma	0.00259	0.00863	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCR3—malignant glioma	0.00254	0.00847	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—APC—malignant glioma	0.00251	0.00836	CbGpPWpGaD
Nabilone—Hypersensitivity—Carmustine—malignant glioma	0.0025	0.00382	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—PTPN11—malignant glioma	0.00246	0.00821	CbGpPWpGaD
Nabilone—CNR1—brain—malignant glioma	0.00244	0.13	CbGeAlD
Nabilone—Asthenia—Carmustine—malignant glioma	0.00243	0.00372	CcSEcCtD
Nabilone—Hypersensitivity—Temozolomide—malignant glioma	0.00242	0.00369	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00239	0.00798	CbGpPWpGaD
Nabilone—Asthenia—Temozolomide—malignant glioma	0.00235	0.00359	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—BDKRB2—malignant glioma	0.00232	0.00775	CbGpPWpGaD
Nabilone—Diarrhoea—Carmustine—malignant glioma	0.00232	0.00354	CcSEcCtD
Nabilone—Pruritus—Temozolomide—malignant glioma	0.00232	0.00354	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—LATS2—malignant glioma	0.00229	0.00764	CbGpPWpGaD
Nabilone—Dizziness—Carmustine—malignant glioma	0.00224	0.00343	CcSEcCtD
Nabilone—Diarrhoea—Temozolomide—malignant glioma	0.00224	0.00343	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—LATS1—malignant glioma	0.00221	0.00738	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00218	0.00726	CbGpPWpGaD
Nabilone—Dizziness—Temozolomide—malignant glioma	0.00217	0.00331	CcSEcCtD
Nabilone—Vomiting—Carmustine—malignant glioma	0.00216	0.00329	CcSEcCtD
Nabilone—Rash—Carmustine—malignant glioma	0.00214	0.00327	CcSEcCtD
Nabilone—Dermatitis—Carmustine—malignant glioma	0.00214	0.00326	CcSEcCtD
Nabilone—Headache—Carmustine—malignant glioma	0.00213	0.00325	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—KNG1—malignant glioma	0.00211	0.00705	CbGpPWpGaD
Nabilone—Vomiting—Temozolomide—malignant glioma	0.00208	0.00318	CcSEcCtD
Nabilone—Rash—Temozolomide—malignant glioma	0.00207	0.00316	CcSEcCtD
Nabilone—Dermatitis—Temozolomide—malignant glioma	0.00207	0.00315	CcSEcCtD
Nabilone—Headache—Temozolomide—malignant glioma	0.00205	0.00314	CcSEcCtD
Nabilone—Nausea—Carmustine—malignant glioma	0.00202	0.00308	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CXCR3—malignant glioma	0.00199	0.00665	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—RAF1—malignant glioma	0.00197	0.00656	CbGpPWpGaD
Nabilone—Nausea—Temozolomide—malignant glioma	0.00195	0.00297	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CCR4—malignant glioma	0.00193	0.00644	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—BDKRB2—malignant glioma	0.00182	0.00608	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00179	0.00598	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—CASP3—malignant glioma	0.00177	0.00589	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCR4—malignant glioma	0.00175	0.00585	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LATS1—malignant glioma	0.00174	0.00579	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—KNG1—malignant glioma	0.00166	0.00553	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL8—malignant glioma	0.00159	0.0053	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCR4—malignant glioma	0.00152	0.00505	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MDK—malignant glioma	0.00149	0.00498	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—STAT3—malignant glioma	0.00148	0.00495	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCR3—malignant glioma	0.00144	0.00479	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DTX1—malignant glioma	0.00143	0.00476	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00141	0.00469	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCR4—malignant glioma	0.00138	0.00459	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—F2—malignant glioma	0.00137	0.00456	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—BDKRB2—malignant glioma	0.00131	0.00438	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCR3—malignant glioma	0.0013	0.00435	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00126	0.00422	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCL8—malignant glioma	0.00125	0.00416	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—KNG1—malignant glioma	0.00119	0.00398	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—BDKRB2—malignant glioma	0.00119	0.00398	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MDK—malignant glioma	0.00117	0.00391	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SUFU—malignant glioma	0.00113	0.00378	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCR3—malignant glioma	0.00113	0.00376	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HEY2—malignant glioma	0.00112	0.00373	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DTX1—malignant glioma	0.00112	0.00373	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GFAP—malignant glioma	0.00109	0.00364	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KNG1—malignant glioma	0.00108	0.00362	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—F2—malignant glioma	0.00107	0.00357	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPHK1—malignant glioma	0.00106	0.00353	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCR4—malignant glioma	0.00104	0.00346	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HEY1—malignant glioma	0.00104	0.00346	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—BDKRB2—malignant glioma	0.00103	0.00344	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCR3—malignant glioma	0.00102	0.00341	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIST1H3B—malignant glioma	0.00101	0.00336	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000992	0.00331	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL8—malignant glioma	0.000963	0.00321	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MMP3—malignant glioma	0.000961	0.0032	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—AKT1—malignant glioma	0.000957	0.00319	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—KNG1—malignant glioma	0.000937	0.00313	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—BDKRB2—malignant glioma	0.000936	0.00312	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JAG2—malignant glioma	0.000919	0.00306	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SUFU—malignant glioma	0.000889	0.00296	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HEY2—malignant glioma	0.000878	0.00293	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GFAP—malignant glioma	0.000858	0.00286	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KNG1—malignant glioma	0.000851	0.00284	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPHK1—malignant glioma	0.00083	0.00277	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR4—malignant glioma	0.000813	0.00271	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HEY1—malignant glioma	0.000813	0.00271	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIST1H3B—malignant glioma	0.00079	0.00263	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—H3F3A—malignant glioma	0.000777	0.00259	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—F2—malignant glioma	0.000772	0.00257	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCR3—malignant glioma	0.00077	0.00257	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL8—malignant glioma	0.000755	0.00252	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MMP3—malignant glioma	0.000754	0.00251	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—YWHAE—malignant glioma	0.000749	0.0025	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NTRK2—malignant glioma	0.000749	0.0025	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FLT1—malignant glioma	0.000746	0.00249	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DUSP6—malignant glioma	0.000743	0.00248	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000739	0.00246	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JAG1—malignant glioma	0.000733	0.00244	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH3—malignant glioma	0.00073	0.00243	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JAG2—malignant glioma	0.000721	0.0024	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FBXW7—malignant glioma	0.000718	0.00239	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BDKRB2—malignant glioma	0.000704	0.00235	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—F2—malignant glioma	0.000701	0.00234	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT2—malignant glioma	0.000676	0.00225	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—malignant glioma	0.000671	0.00224	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTPN11—malignant glioma	0.000659	0.0022	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH2—malignant glioma	0.000655	0.00218	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000649	0.00217	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KNG1—malignant glioma	0.000641	0.00214	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT2—malignant glioma	0.000614	0.00205	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NTRK1—malignant glioma	0.000611	0.00204	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—H3F3A—malignant glioma	0.00061	0.00203	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—F2—malignant glioma	0.000606	0.00202	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCR3—malignant glioma	0.000604	0.00202	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CD—malignant glioma	0.00059	0.00197	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—YWHAE—malignant glioma	0.000588	0.00196	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NTRK2—malignant glioma	0.000588	0.00196	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FLT1—malignant glioma	0.000585	0.00195	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DUSP6—malignant glioma	0.000583	0.00194	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—malignant glioma	0.00058	0.00193	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JAG1—malignant glioma	0.000575	0.00192	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH3—malignant glioma	0.000573	0.00191	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP3—malignant glioma	0.000568	0.00189	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000566	0.00189	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FBXW7—malignant glioma	0.000564	0.00188	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN2B—malignant glioma	0.000563	0.00188	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BDKRB2—malignant glioma	0.000553	0.00184	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—F2—malignant glioma	0.00055	0.00183	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTK2—malignant glioma	0.000546	0.00182	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—malignant glioma	0.000544	0.00181	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HES1—malignant glioma	0.000537	0.00179	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NCOR1—malignant glioma	0.000534	0.00178	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT2—malignant glioma	0.00053	0.00177	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—RAF1—malignant glioma	0.000527	0.00176	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—malignant glioma	0.000526	0.00176	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—IL2—malignant glioma	0.00052	0.00173	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTPN11—malignant glioma	0.000517	0.00172	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CB—malignant glioma	0.000514	0.00171	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH2—malignant glioma	0.000514	0.00171	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFRA—malignant glioma	0.000511	0.0017	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CD—malignant glioma	0.00051	0.0017	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KNG1—malignant glioma	0.000503	0.00168	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPP1—malignant glioma	0.000496	0.00165	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL8—malignant glioma	0.000494	0.00165	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT2—malignant glioma	0.000482	0.00161	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NTRK1—malignant glioma	0.000479	0.0016	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL2—malignant glioma	0.000472	0.00157	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TERT—malignant glioma	0.00047	0.00157	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CD—malignant glioma	0.000463	0.00154	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFB—malignant glioma	0.000459	0.00153	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGFR1—malignant glioma	0.000457	0.00152	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIF1A—malignant glioma	0.00045	0.0015	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP3—malignant glioma	0.000445	0.00149	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000444	0.00148	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN2B—malignant glioma	0.000442	0.00147	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CAV1—malignant glioma	0.000435	0.00145	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KDR—malignant glioma	0.00043	0.00143	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTK2—malignant glioma	0.000429	0.00143	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—malignant glioma	0.000427	0.00142	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HES1—malignant glioma	0.000421	0.0014	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NCOR1—malignant glioma	0.000419	0.0014	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FN1—malignant glioma	0.000414	0.00138	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—F2—malignant glioma	0.000414	0.00138	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RAF1—malignant glioma	0.000413	0.00138	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BAD—malignant glioma	0.000409	0.00136	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IL2—malignant glioma	0.000408	0.00136	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH1—malignant glioma	0.000405	0.00135	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000403	0.00135	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFRA—malignant glioma	0.000401	0.00134	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CD80—malignant glioma	0.000397	0.00132	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APC—malignant glioma	0.000396	0.00132	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CG—malignant glioma	0.000396	0.00132	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGF—malignant glioma	0.000392	0.00131	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTPN11—malignant glioma	0.000389	0.0013	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPP1—malignant glioma	0.000389	0.0013	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL8—malignant glioma	0.000388	0.00129	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BRAF—malignant glioma	0.000373	0.00124	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL2—malignant glioma	0.00037	0.00124	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TERT—malignant glioma	0.000369	0.00123	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT2—malignant glioma	0.000363	0.00121	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—malignant glioma	0.000361	0.0012	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFB—malignant glioma	0.00036	0.0012	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGFR1—malignant glioma	0.000358	0.0012	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIF1A—malignant glioma	0.000353	0.00118	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CD—malignant glioma	0.000348	0.00116	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000345	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CAV1—malignant glioma	0.000341	0.00114	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KRAS—malignant glioma	0.000341	0.00114	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KDR—malignant glioma	0.000338	0.00113	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FGF2—malignant glioma	0.000334	0.00111	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FN1—malignant glioma	0.000325	0.00108	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—F2—malignant glioma	0.000325	0.00108	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BAD—malignant glioma	0.000321	0.00107	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH1—malignant glioma	0.000318	0.00106	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—malignant glioma	0.000313	0.00105	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MDM2—malignant glioma	0.000312	0.00104	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CD80—malignant glioma	0.000312	0.00104	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAF1—malignant glioma	0.000311	0.00104	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APC—malignant glioma	0.000311	0.00104	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CG—malignant glioma	0.000311	0.00104	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—malignant glioma	0.000308	0.00103	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGF—malignant glioma	0.000307	0.00103	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTPN11—malignant glioma	0.000306	0.00102	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CB—malignant glioma	0.000304	0.00101	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BRAF—malignant glioma	0.000292	0.000975	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—malignant glioma	0.000292	0.000973	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT2—malignant glioma	0.000285	0.000949	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—malignant glioma	0.000283	0.000945	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—malignant glioma	0.000282	0.00094	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—malignant glioma	0.000279	0.000931	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—malignant glioma	0.000279	0.00093	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CD—malignant glioma	0.000273	0.000912	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000271	0.000903	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KRAS—malignant glioma	0.000268	0.000893	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—malignant glioma	0.000264	0.00088	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTEN—malignant glioma	0.000262	0.000875	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGF2—malignant glioma	0.000262	0.000873	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—malignant glioma	0.000256	0.000854	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—malignant glioma	0.000246	0.00082	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MDM2—malignant glioma	0.000245	0.000817	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAF1—malignant glioma	0.000244	0.000814	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—malignant glioma	0.000241	0.000805	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CB—malignant glioma	0.000238	0.000795	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—malignant glioma	0.000237	0.00079	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—malignant glioma	0.000235	0.000783	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—malignant glioma	0.000229	0.000764	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—malignant glioma	0.000221	0.000738	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—malignant glioma	0.000219	0.000731	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—malignant glioma	0.000219	0.00073	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—malignant glioma	0.000218	0.000727	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—malignant glioma	0.000213	0.000711	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—malignant glioma	0.000207	0.000691	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTEN—malignant glioma	0.000206	0.000687	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—malignant glioma	0.000202	0.000672	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—malignant glioma	0.000201	0.00067	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—malignant glioma	0.000186	0.00062	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—malignant glioma	0.000185	0.000617	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—malignant glioma	0.000184	0.000614	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—malignant glioma	0.000179	0.000597	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—malignant glioma	0.000171	0.000571	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—malignant glioma	0.000167	0.000558	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—malignant glioma	0.000158	0.000527	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—malignant glioma	0.000151	0.000504	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—malignant glioma	0.000145	0.000484	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—malignant glioma	0.000141	0.000469	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—malignant glioma	0.000119	0.000396	CbGpPWpGaD
